
---
title: 'WHO狂犬病预防控制指南：最新更新选介（2）'
categories: 
 - 新媒体
 - 科学网
 - 博客
headimg: 'https://picsum.photos/400/300?random=4308'
author: 科学网
comments: false
date: Thu, 15 Sep 2022 10:19:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=4308'
---

<div>   
<h1 style="margin-top: 15px;margin-right: 0;margin-bottom: 15px;padding: 0;line-height: 200%"><strong><span style="font-family: 'Arial Unicode MS';line-height: 200%;font-size: 29px">WHO</span></strong><strong><span style="font-family: 'Arial Unicode MS';line-height: 200%;font-size: 29px">狂犬病预防控制指南</span></strong><strong><span style="font-family: 'Arial Unicode MS';line-height: 200%;font-size: 29px"><span style="font-family:Arial Unicode MS">：最新更新选介（</span><span style="font-family:Arial Unicode MS">2）</span></span></strong></h1><p><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #069A2E;letter-spacing: 0;font-size: 24px">前言</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #069A2E;letter-spacing: 0;font-size: 24px">：</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #069A2E;letter-spacing: 0;font-size: 24px">今年７月</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #069A2E;letter-spacing: 0;font-size: 24px">29 </span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #069A2E;letter-spacing: 0;font-size: 24px">日，</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #069A2E;letter-spacing: 0;font-size: 24px">WHO</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #069A2E;letter-spacing: 0;font-size: 24px">官网发布了一个英文手册，标题是</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #069A2E;letter-spacing: 0;font-size: 24px">Guide to introducing human rabies vaccine into national immunization programmes</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #069A2E;letter-spacing: 0;font-size: 24px">（</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #069A2E;letter-spacing: 0;font-size: 24px">将人狂犬病疫苗引入国家免疫规划指南</span></strong><strong><span style="font-family: 'Microsoft YaHei UI';line-height: 200%;color: #069A2E;letter-spacing: 0;font-size: 24px">）（见参考文献），在其正文和附录中全面介绍了ＷＨＯ对狂犬病疫苗的使用规范和对相关问题的权威解答。本博客将陆续选介其中部分内容以飨读者。</span></strong><br></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;color: #0000FF;font-size: 29px">狂犬病疫苗的禁忌症和预防措施</span></strong></p><p style="margin-left:0;text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:SimSun;line-height:200%;font-size:21px">考虑到临床狂犬病几乎不可避免的致命后果，</span><strong><span style="font-family: SimSun;line-height: 200%;color: #FF0000;font-size: 21px">狂犬病疫苗没有禁忌症</span></strong><span style=";font-family:SimSun;line-height:200%;font-size:21px">。任何可疑的狂犬病毒接触都应按照建议的时间表立即接种狂犬病疫苗进行处治。</span><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px">怀孕和哺乳不是</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">PEP</span><a name="OLE_LINK1" href="http://blog.sciencenet.cn/undefined"></a><span style="font-family:SimSun">（暴露后预防）</span></span></span></strong><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px">的禁忌症。</span></strong><span style=";font-family:SimSun;line-height:200%;font-size:21px">接受</span><span style="text-decoration:underline;"><span style="font-family: SimSun;line-height: 200%;font-size: 21px">氯喹</span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px">或</span><span style="text-decoration:underline;"><span style="font-family: SimSun;line-height: 200%;font-size: 21px">羟氯喹</span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:SimSun">治疗的个体无禁忌症</span><span style="font-family:Calibri">;</span><span style="font-family:SimSun">可采用皮内或肌肉注射方式接种疫苗。对疫苗生产商列出的任何成分或辅料有</span></span><span style="text-decoration:underline;"><span style="font-family: SimSun;line-height: 200%;font-size: 21px">严重过敏史</span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px">的个人应接受其他生产商生产的替代的狂犬病疫苗产品。</span></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;color: #0000FF;font-size: 29px"><span style="font-family:SimSun">狂犬病</span><span style="font-family:Calibri">PEP</span><span style="font-family:SimSun">（暴露后预防）的安全性和不良事件</span></span></strong></p><p style="margin-left:0;text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:SimSun;line-height:200%;font-size:21px">与其他疫苗一样，</span><strong><span style="text-decoration: underline; font-family: SimSun; line-height: 200%; font-size: 21px;">局部反应</span></strong><span style="line-height: 200%; font-size: 21px; font-family: Calibri;">(</span><span style="text-decoration: underline; font-family: SimSun; line-height: 200%; font-size: 21px;">如注射部位发红、疼痛、肿胀和硬结</span><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:Calibri">)</span><span style="font-family:SimSun">是接种狂犬病疫苗后报告最多的不良事件，发生在</span><span style="font-family:Calibri">35-45%</span><span style="font-family:SimSun">的疫苗接种者中。</span><span style="font-family:Calibri">5-15%</span><span style="font-family:SimSun">的疫苗接种者在免疫接种后可能出现轻微的</span></span><strong><span style="text-decoration: underline; font-family: SimSun; line-height: 200%; font-size: 21px;">全身不良事</span></strong><span style=";font-family:SimSun;line-height:200%;font-size:21px">件，如短暂发热、头痛、头晕和胃肠道症状。免疫接种后的</span><strong><span style="text-decoration: underline; font-family: SimSun; line-height: 200%; font-size: 21px;">严重不良事件极少发生</span></strong><span style=";font-family:SimSun;line-height:200%;font-size:21px">，在极个别发生了</span><strong><span style="text-decoration: underline; font-family: SimSun; line-height: 200%; font-size: 21px;">神经系统症状</span></strong><span style=";font-family:SimSun;line-height:200%;font-size:21px">的病例中</span><span style="font-family: SimSun; line-height: 200%; font-size: 21px; text-decoration: underline;">与疫苗接种未能确定因果关系</span><span style=";font-family:SimSun;line-height:200%;font-size:21px">。</span></p><p style="margin-left:0;text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:SimSun">有关狂犬疫苗接种后不良事件的详细信息，请参阅生产商随疫苗提供的包装说明书。与其他疫苗一样，实施狂犬病</span><span style="font-family:Calibri">PEP</span><span style="font-family:SimSun">的卫生机构应具备管理和处置</span></span><strong><span style="text-decoration:underline;"><span style="font-family: SimSun;line-height: 200%;font-size: 21px">严重过敏反应</span></span></strong><span style=";font-family:SimSun;line-height:200%;font-size:21px"><span style="font-family:SimSun">的能力，并在接种疫苗后将疫苗接受者置于医疗监护下</span><span style="font-family:Calibri">15-20</span><span style="font-family:SimSun">分钟。</span></span></p><p style="margin-left:0;text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:SimSun;line-height:200%;font-size:21px">使用</span><strong><span style="text-decoration:underline;"><span style="font-family: SimSun;line-height: 200%;font-size: 21px"><span style="font-family:Calibri">RIG</span><span style="font-family:SimSun">（狂犬病免疫球蛋白</span></span></span></strong><span style=";font-family:SimSun;line-height:200%;font-size:21px">）的医生应该作好治疗</span><span style="text-decoration:underline;"><span style="font-family: SimSun;line-height: 200%;font-size: 21px">过敏反应</span></span><span style=";font-family:SimSun;line-height:200%;font-size:21px">的准备，尽管罕见，但可能发生在其给药的任何阶段。</span></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;color: #0000FF;font-size: 29px">（不同品牌）狂犬病疫苗的可互换性</span></strong></p><p style="margin-left:0;text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:SimSun;line-height:200%;font-size:21px">在狂犬病疫苗接种过程中，应尽量不要发生狂犬病疫苗产品的改变，但</span><strong><span style="text-decoration: underline; font-family: SimSun; line-height: 200%; font-size: 21px;">如果这种改变是不可避免的，则是可以接受的</span></strong><span style="line-height: 200%; font-size: 21px; font-family: SimSun;">。</span><span style="font-family: SimSun; line-height: 200%; font-size: 21px; text-decoration: underline;">没有必要重新启动一系列注射</span><span style="line-height: 200%; font-size: 21px; font-family: Calibri;">;</span><span style="font-family: SimSun; line-height: 200%; font-size: 21px; text-decoration: underline;"><strong>疫苗接种应按照原计划继续进行</strong></span><span style="line-height: 200%; font-size: 21px; font-family: SimSun;">。目前尚无数据支持神经组织狂犬病疫苗（注：</span><span style=";font-family:Calibri;line-height:200%;font-size:21px">WHO</span><span style=";font-family:SimSun;line-height:200%;font-size:21px">早已在全球禁用此类疫苗</span><span style=";font-family:Calibri;line-height:200%;font-size:21px">)</span><span style=";font-family:SimSun;line-height:200%;font-size:21px">与细胞培养和</span><strong><span style="text-decoration: underline; font-family: SimSun; line-height: 200%; font-size: 21px;"><span style="font-family:SimSun">禽胚胎卵细胞狂犬病疫苗</span><span style="font-family:Calibri">(CCEEV)</span></span></strong><span style=";font-family:SimSun;line-height:200%;font-size:21px">的互换性。应停止使用所有神经组织狂犬病疫苗，转而使用</span><strong><span style="text-decoration: underline; line-height: 200%; font-size: 21px; font-family: Calibri;">CCEEV</span></strong><span style=";font-family:SimSun;line-height:200%;font-size:21px">。</span></p><p style="margin-left:0;text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:SimSun;line-height:200%;font-size:21px">（未完待续）</span></p><p style="line-height: 200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px">参考文献：</span></strong></p><p style="margin-left: 0px; text-indent: 37px; line-height: 200%;"><span style="font-family: Helvetica;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 19px;background: #FFFFFF">World Health Organization. (‎2022)‎. Guide to introducing human rabies vaccine into national immunization programmes. World Health Organization.</span><span style="font-family: Arial;line-height: 200%;color: #6A6A6A;letter-spacing: 0;font-size: 19px">29 July 2022</span><span style="font-family: SimSun;line-height: 200%;color: #6A6A6A;letter-spacing: 0;font-size: 19px">，</span><a href="https://apps.who.int/iris/handle/10665/360978" target="_blank"><span style="font-family: Helvetica;line-height: 200%;color: #008DC9;letter-spacing: 0;font-size: 19px;background: #FFFFFF">https://apps.who.int/iris/handle/10665/360978</span></a><span style="font-family: Helvetica;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 19px;background: #FFFFFF">. License: CC BY-NC-SA 3.0 IGO</span><span style="font-family: Helvetica;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 19px;background: #FFFFFF"><span style="font-family:Helvetica">.</span></span></p>                    <br><br>
                                        <label style="font-size:13px; color:#850f0f">转载本文请联系原作者获取授权，同时请注明本文来自严家新科学网博客。<br>链接地址：</label><a href="https://blog.sciencenet.cn/blog-347754-1355411.html" target="_blank" style="font-size:13px; color:#850f0f">https://blog.sciencenet.cn/blog-347754-1355411.html </a>
  <br><br>上一篇：<a href="http://blog.sciencenet.cn/blog-347754-1355293.html" target="_black">WHO狂犬病预防控制指南：最新更新选介（１）</a><br>                    <!--大赛结束-->
                                        
  
</div>
            